Moderna is in the process of integrating generative AI responsibly and seamlessly into its operations and capitalizing on next-generation AI innovation.
Enables Bristol Myers Squibb to expand its manufacturing capacity, meeting the growing demand for its range of cell therapies through Cellares’ platform.